A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 581
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CIPN
Long Form : Chemotherapy-induced peripheral neuropathy
No. Year Title Co-occurring Abbreviation
2020 A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models. ---
2020 A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention. ---
2020 A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN). BPI, ST
2020 An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. CI, OR
2020 Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity. TNSc
2020 Assessing the utility of in vitro microtubule assays for studying mechanisms of peripheral neuropathy with the microtubule inhibitor class of cancer chemotherapy. MT, MTI
2020 Clinical study on concurrent use of electro-acupuncture or Chuna manual therapy with pregabalin for chemotherapy-induced peripheral neuropathy: safety and effectiveness (open-labeled, parallel, randomized controlled trial, assessor-blinded): A study protocol. CMT, EA
2020 Effect of serotonin-norepinephrine reuptake inhibitors for patients with chemotherapy-induced painful peripheral neuropathy: A meta-analysis. SNRIs
2020 Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study. CRC, QOL
10  2020 Enolate-forming compounds provide protection from platinum neurotoxicity. CisPt, HSAB, Pt
11  2020 Incidence of chemotherapy-induced peripheral neuropathy within 12weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study. ---
12  2020 Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy. ALCAR, CIM
13  2020 Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress. ODN
14  2020 Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations. MSC
15  2020 Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations. ---
16  2020 Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy. CI, FGs, QOL
17  2020 Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients. NCS, OPN, QOL, TIN
18  2020 Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes. CMT, PRO, SNV
19  2020 Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer. CSA, IENFD, NMUS
20  2020 Notch activation enhances microglial CX3CR1/P38 MAPK pathway in rats model of vincristine-induced peripheral neuropathy. DAPT, VCR
21  2020 Out of balance - Postural control in cancer patients before and after neurotoxic chemotherapy. BPEO, COP, HMC, MPEO, pat
22  2020 Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study. CHIP, TAPS
23  2020 Pilot study of repetitive transcranial magnetic stimulation in patients with chemotherapy-induced peripheral neuropathy. rTMS, SFMPQ2
24  2020 Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. ---
25  2020 Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study. ---
26  2020 Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial. PROs, TENS
27  2020 Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies. hTRPM8, MD, TRPM8, WDS
28  2020 Study of the possible synergistic protective effects of Melatonin and Pregabalin in Vincristine induced peripheral neuropathy Wistar Albino rats. MDA, VCR
29  2020 Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy. IL-20
30  2020 Taxane-induced peripheral neuropathy: differences in patient report and objective assessment. LI, NCS
31  2020 The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial. CCMQ, NRS
32  2020 The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy. ---
33  2020 Topical combination of meldonium and N-acetyl cysteine relieves allodynia in rat models of CRPS-1 and peripheral neuropathic pain by enhancing NO-mediated tissue oxygenation. CCI, CPIP, CRPS, NAC, NO
34  2019 A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer. ---
35  2019 A Narrative Review of Complementary Nutritional Supplements for Chemotherapy-induced Peripheral Neuropathy. ---
36  2019 A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models. DOR, MOR
37  2019 A Randomized Controlled Trial to Assess the Effectiveness of Muscle Strengthening and Balancing Exercises on Chemotherapy-Induced Peripheral Neuropathic Pain and Quality of Life Among Cancer Patients. QOL
38  2019 A review of complementary therapies with medicinal plants for chemotherapy-induced peripheral neuropathy. ---
39  2019 A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN). ---
40  2019 Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. BPI-SF, CG, FACT-NTX, IA, PNQ
41  2019 Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study. NCI-CTCAE, QOL
42  2019 Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors. ---
43  2019 Alleviation of paclitaxel-induced mechanical hypersensitivity and hyperalgesic priming with AMPK activators in male and female mice. AMPK, LKB1, MAPK, mTOR
44  2019 Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy. ---
45  2019 Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysis. SMD
46  2019 Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry. CRC
47  2019 Are Ergothioneine Levels in Blood Associated with Chronic Peripheral Neuropathy in Colorectal Cancer Patients Who Underwent Chemotherapy? CRC, ET, PR
48  2019 Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. ---
49  2019 Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments. ---
50  2019 Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. ---
51  2019 Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy. ---
52  2019 Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain. SNRIs
53  2019 Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers. DRG, HDAC6, IENFs
54  2019 Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review. ASCO
55  2019 Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches. ---
56  2019 Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain. PNS
57  2019 Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data. RR
58  2019 Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing. NPS, NRS, PRO, QST
59  2019 Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study. ---
60  2019 Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade. PRO
61  2019 Chemotherapy-Induced Peripheral Neuropathy: Association With Increased Risk of Falls and Injuries. ---
62  2019 Chemotherapy-induced peripheral neuropathy: where are we now? HDAC6
63  2019 Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue. ---
64  2019 Circulating microRNA and automated motion analysis as novel methods of assessing chemotherapy-induced peripheral neuropathy in mice. DRG, miRNA
65  2019 Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice. ---
66  2019 Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy: A mediation effect analysis. QOL, RDA
67  2019 Deleterious Effects of Higher Body Mass Index on Subjective and Objective Measures of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors. BMI
68  2019 Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer. CAS-CIPN
69  2019 DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain. ---
70  2019 Diffusion Tensor Imaging of the Ankle as a Possible Predictor of Chemotherapy Induced Peripheral Neuropathy: Pilot Study. ADC, DTI, FA, MRN, VPT
71  2019 Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model. Ar, FAAH
72  2019 Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain. QOL
73  2019 Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture. DRG
74  2019 Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-kappaB. ASCO, NGF, OXA, PTX
75  2019 Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast cancer. HR
76  2019 Effect of diabetes on neurological adverse effects and chemotherapy induced peripheral neuropathy in advanced colorectal cancer patients treated with different FOLFOX regimens. CRC
77  2019 Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial. IE
78  2019 Effectiveness of Somatic Yoga and Meditation: A Pilot Study in a Multicultural Cancer Survivor Population with Chemotherapy-Induced Peripheral Neuropathy. ---
79  2019 Effects of aroma self-foot reflexology on peripheral neuropathy, peripheral skin temperature, anxiety, and depression in gynaecologic cancer patients undergoing chemotherapy: A randomised controlled trial. IMCHB
80  2019 Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms. ---
81  2019 Efficacy of a topical gabapentin gel in a cisplatin paradigm of chemotherapy-induced peripheral neuropathy. PWL, PWT
82  2019 Efficacy of topical Citrullus colocynthis (bitter apple) extract oil in chemotherapy-induced peripheral neuropathy: A pilot double-blind randomized placebo-controlled clinical trial. FACT/GOG
83  2019 Evidence that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity: An electron paramagnetic resonance study. ---
84  2019 Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. ---
85  2019 Exploring the Roles of Central and Peripheral Nervous System Function in Gait Stability: Preliminary Insights from Cancer Survivors. ---
86  2019 Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy. ---
87  2019 Feasibility of quantitative sensory testing (QST) in clinical routine as a tool to evaluate chemotherapy-induced peripheral neuropathy (CIPN) amongst breast cancer patients treated with taxanes. QST
88  2019 High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies. VAS
89  2019 High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy. DRG, HMGB-1, MMP, NAC, TLR4
90  2019 Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathyin Cancer Therapy Evaluation Program-sponsored phase I trials. NCI
91  2019 Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors. FR, PNQ, QOL, SR, SYM, TUG
92  2019 Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study. ---
93  2019 Incidence of peripheral neuropathy associated with eribulin mesylate versus vinorelbine in patients with metastatic breast cancer: sub-group analysis of a randomized phase III study. ECOG PS
94  2019 Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH. WBV
95  2019 Inflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J Mice. ---
96  2019 Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis. CRC, HFS, NCI-CTCAE, RCTs, RR, WHO
97  2019 Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice. ---
98  2019 It's never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial. CG
99  2019 Kinematic evaluation for impairment of skilled hand function in chemotherapy-induced peripheral neuropathy. ---
100  2019 Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity. CBD, DRG, IR, mNCX-1, siRNA